Search results
Nail Psoriasis
Health via Yahoo News· 1 week agoLiving With Nail Psoriasis Nail psoriasis won’t affect your life expectancy or cause other health conditions. However, if your nail psoriasis< ...
Low stress resilience is linked to increased risk of psoriasis
Medical Xpress· 5 days agoAs part of the enlistment process, all the men underwent psychological assessment in accordance with...
It Took Me Years to Find the Right Psoriatic Arthritis Medication
Verywell Health via Yahoo News· 2 weeks agoAfter being diagnosed with psoriatic arthritis in 2016, it took LB Herbert years to find a psoriatic...
Coexistence of psoriatic arthritis, atopic dermatitis may offer treatment insights
Medical Xpress· 2 weeks agoPsoriatic arthritis (PsA) and atopic dermatitis (AD) can coexist, and the presence of both...
Finding the Best Psoriasis Treatment: How I Got Psoriasis Relief
Verywell Health via Yahoo News· 5 days agoTakeaway Humira was one of the first biologic medications approved for psoriatic arthritis in 2005...
J&J’s Tremfya meets endpoints in Phase III ulcerative colitis trial
Clinical Trials Arena via Yahoo Finance· 5 days agoJ&J’s Tremfya is expected to be the successor to the company’s IL-12/IL-23 inhibitor Stelara...
Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S.
Morningstar· 6 days ago“We are proud to make SIMLANDI available in the U.S. to patients and providers,” said Thomas Rainey, Senior...
Alvotech (NYSE:ALVO) Releases Quarterly Earnings Results, Misses Estimates By $0.81 EPS
ETF DAILY NEWS· 2 days agoAlvotech (NYSE:ALVO – Get Free Report) issued its quarterly earnings data on Wednesday. The company reported ($0.89) earnings per share for the quarter, missing analysts’ consensus estimates ...
7 Biotech Stocks That Could Breathe New Life Into Your Portfolio
InvestorPlace via Yahoo Finance· 6 days agoFundamentally, one of the biggest advantages of biotech stocks to buy centers on the underlying...
Johnson & Johnson (NYSE:JNJ) Shares Sold by Smithfield Trust Co
ETF DAILY NEWS· 2 weeks agoSmithfield Trust Co lessened its position in Johnson & Johnson (NYSE:JNJ – Free Report) by 2.0% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional ...
